Advertisement

Featured in NEJM Journal Watch: Progress Toward All-Oral, Interferon-Free Therapy for HCV Genotype 1 Infection — Physician’s First Watch

Medical News |
January 16, 2014

Featured in NEJM Journal Watch: Progress Toward All-Oral, Interferon-Free Therapy for HCV Genotype 1 Infection

By the NEJM Journal Watch Editors

Interferon-free treatments for hepatitis C achieved high virologic response with low resistance and few adverse effects in two open-label studies in the New England Journal of Medicine.

In NEJM Journal Watch, Atif Zaman writes: "Soon, all-oral regimens for every HCV-infected patient will be a reality."

Reader Comments (1)

J.L. Brown, MD Physician, Family Medicine/General Practice, Little cubicle in big building

This holds great promise.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement